Product Description:

Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with Methotrexate.

Product Features:

Product Name : Baricinix
Generic Name : Baricitinib
Formulation : Tablet
Available Pack Size : 30’s Pot
Available Strength : 2mg & 4mg
Registrations : Export Only
Website :